REGENERON PHARMACEUTICALS, INC.

13F Portfolio Filings

  • Most recent 13F
    Q4 2024
  • Location
    tarrytown, NY
  • CIK
    0000872589
  • All SEC filings
Q4 2024
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

6

$1.09B
ALNY, NTLA, TSVT, ACET
13F-HR
Feb 7, 2025
000110465925010583
Regeneron Pharmaceuticals, Inc. 13F Filings